|
2004 Conference Publication What is the role of transmembrane domain 2 (TMD2) in noradrenaline transporter (NET) function?Sucic, S. and Lluka, L.J. (2004). What is the role of transmembrane domain 2 (TMD2) in noradrenaline transporter (NET) function?. 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Australia, 1-6 August 2004. Australia: Blackwell Publishing Asia Pty Ltd. |
|
2004 Conference Publication How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?Paczkowski, F. A., Wanstall, J. C. and Lluka, L.J. (2004). How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?. 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Australia, 1-6 August 2004. Australia: Blackwell Publishing Asia Pty Ltd. |
|
2003 Conference Publication Evidence for different, but overlapping, binding sites on the human noradrenaline transporter (hNET) for substrates, antidepressants and cocainePaczkowski, F. A., Sucic, S. and Bryan-Lluka, L. J. (2003). Evidence for different, but overlapping, binding sites on the human noradrenaline transporter (hNET) for substrates, antidepressants and cocaine. Summer Meeting of the British Association for Psychopharmacology, Cambridge, England, 20-23 July 2003. Oxford, United Kingdom: Sage Productions. |
|
2001 Conference Publication Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporterPaczkowski, F. A., Sucic, S. and Bryan-Lluka, L. J. (2001). Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporter. The 9th International Catecholamine Symposium, Kyoto, Japan/Kyoto International Conference Hall, 31 March - 5 April 2001. Kyoto, Japan: N/A. |
|
2001 Conference Publication Regulation of the norepinephrine transporter (NET) and the serotonin transporter (SERT) by second messengers and hormonesBryan-Lluka, L. J., Dunner, E. M. and Papacostas, M. H. (2001). Regulation of the norepinephrine transporter (NET) and the serotonin transporter (SERT) by second messengers and hormones. 9th International Catecholamine Symposium, Kyoto, Japan/Kyoto International Conference Hall, 31 March - 5 April, 2001. Kyoto, Japan: |
|
2001 Conference Publication 5-hydroxytryptamine and platelet function in hypoxic pulmonary hypertensive rats: Studies on uptake and aggregationAwabdy, D., Bryan-Lluka, L. J. and Wanstall, J. C. (2001). 5-hydroxytryptamine and platelet function in hypoxic pulmonary hypertensive rats: Studies on uptake and aggregation. ASCEPT Annual Scientific Meeting, University of Otago, Dunedin, New Zealand, 3-5 December, 2001. Victoria, Australia: ASCEPT. |
|
2001 Conference Publication A naturally occurring human noradrenaline transporter mutation in transmembrane domain 9 causes differential changes in noradrenaline and cocaine affinities Abstracts of the . .Bryan-Lluka, L. J., Bonisch, H. and Paczkowski, F. A. (2001). A naturally occurring human noradrenaline transporter mutation in transmembrane domain 9 causes differential changes in noradrenaline and cocaine affinities Abstracts of the . .. British Pharmacological Society Meeting, United Kingdom, 5-7 September, 2001. London, England: |
|
2000 Conference Publication Mutations in transmembrane domain (TMD) 5 of the human noradrenaline transporter (hNAT) cause increases in substrate affinities but decreases in inhibitor affinitiesBryan-Lluka, L. J. and Paczkowski, F. A. (2000). Mutations in transmembrane domain (TMD) 5 of the human noradrenaline transporter (hNAT) cause increases in substrate affinities but decreases in inhibitor affinities. Joint Meeting of ASCEPT and the British Pharmacological Society, Newcastle, Australia, 3 - 6 December, 2000. Melbourne, Australia: ASCEPT. |
|
2000 Conference Publication Cell Type Dependent Regulation of the NA Transporter (NAT) and 5HT Transporter (SERT) by cAMPDunner, E. M. and Bryan-Lluka, L. J. (2000). Cell Type Dependent Regulation of the NA Transporter (NAT) and 5HT Transporter (SERT) by cAMP. The Australasian, Newcastle, Australia, 3 - 6 December, 2000. Melbourne, Australia: ASCEPT. |
|
2000 Conference Publication Role of two amino acids in pharmacological differences between human and rat NA transportersBryan-Lluka, L. J. and Paczkowski, F. A. (2000). Role of two amino acids in pharmacological differences between human and rat NA transporters. Joint Meeting of ASCEPT and the British Pharmacological Society, Melbourne, Australia, 25 - 28 April, 2000. Melbourne, Australia: ASCEPT. |
|
2000 Conference Publication Importance of the first intracellular loop in the activity of the human noradrenaline transporter (hNAT)Sucic, S. and Bryan-Lluka, L. J. (2000). Importance of the first intracellular loop in the activity of the human noradrenaline transporter (hNAT). Joint Meeting of ASCEPT and the British Pharmacological Society, Newcastle, Australia, 3 - 6 December, 2000. Melbourne, Australia: ASCEPT. |
|
1999 Conference Publication Mechanism of 5-HT transporter (SERT) regulation by thyrosinePapacostas, M. and Bryan-Lluka, L. J. (1999). Mechanism of 5-HT transporter (SERT) regulation by thyrosine. 33rd Annual Scientific Meeting of ASCEPT, Sydney Convention & Exhibition Cen., Sydney, 4 - 8 December, 1999. Melbourne: Blackwell Scientific Publications. |
|
1999 Conference Publication Norepinephrine (NE) transporter (NET) and serotonin (5-HT) transporter (SERT) regulation by thyroxine (T4), angiotensin II (AII) and insulin (INS)Bryan-Lluka, L. J. and Boyd, S. M. (1999). Norepinephrine (NE) transporter (NET) and serotonin (5-HT) transporter (SERT) regulation by thyroxine (T4), angiotensin II (AII) and insulin (INS). 42nd Annual Meeting of the Western Pharmacology Society, Maui, Hawwaii, USA, 30 Jan - 04 Feb, 1999. Seattle, USA: Western Pharacological Society. |
|
1999 Conference Publication Regulation of noradrenaline transporter (NAT) and 5-HT transporter (SERT) activity by inhibitors and substratesBryan-Lluka, L. J., Ha, L. D. Q. and Boyd, S. M. (1999). Regulation of noradrenaline transporter (NAT) and 5-HT transporter (SERT) activity by inhibitors and substrates. 33rd Annual Scientific Meeting of ASCEPT, Sydney Convention & Exhibition Cen., Sydney, 4 - 8 December, 1999. Melbourne: Blackwell Scientific Publications. |
|
1999 Conference Publication Interactions of Haloperidol (HP) Metabolites with transporters for Dopamine (DAT), Norepinephrine (NET) and Serotonin (SERT)Siebert, G. A., Pond, S. M. and Bryan-Lluka, L. J. (1999). Interactions of Haloperidol (HP) Metabolites with transporters for Dopamine (DAT), Norepinephrine (NET) and Serotonin (SERT). 42nd Annual Meeting of the Western Pharmacology Society, Maui, Hawaii, USA, 30 Jan - 04 Feb, 1999. Seattle, USA: Western Pharmacological Society. |
|
1999 Conference Publication Effects of mutation of phenylalanine-531 on rat noradrenaline transporter activityPaczkowski, F. A. and Bryan-Lluka, L. J. (1999). Effects of mutation of phenylalanine-531 on rat noradrenaline transporter activity. 33rd Annual Scientific Meeting of ASCEPT, Sydney, 4 - 8 December, 1999. Melbourne: Blackwell Scientific Publications. |
|
1999 Conference Publication Thyroxine causes cell type-dependent regulation of the serotonin and noradrenaline transportersBryan-Lluka, L. J., Boyd, S. M. and Papacostas, M. H. (1999). Thyroxine causes cell type-dependent regulation of the serotonin and noradrenaline transporters. British Pharmacological Society Meeting, University of Leeds, UK, 8 - 10 September, 1999. Hampshire, UK: Stockton Press - Div. of Macmillan Press Ltd. |
|
1991 Conference Publication The effects of type 1 diabetes mellitus and of tobacco smoke on dissipation of catecholamines in pulmonary endothelial cells — a non-neuronal site of uptake1Bryan-Lluka, L. J. and McKee, G. J. (1991). The effects of type 1 diabetes mellitus and of tobacco smoke on dissipation of catecholamines in pulmonary endothelial cells — a non-neuronal site of uptake1. Recent Advanced in Neuropharmacology, Würzburg, Germany, 22-24 March 1991. Vienna, Austria: Springer. |
